5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts: The randomized BARRICADE (Barrier Approach to Restenosis: Restrict Intima to Curtail Adverse Events) trial

JACC: Cardiovascular Interventions

Volumn 4, Issue 3, 2011, Pages 300-309

  Stone, Gregg W ^a,f   Goldberg, Sheldon ^b   O'Shaughnessy, Charles ^c   Midei, Mark ^d   Siegel, Robert M ^e   Cristea, Ecaterina ^a   Dangas, George ^a   Lansky, Alexandra J ^a   Mehran, Roxana ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^c EMH Regional Medical Center   (United States)

^d St Joseph's Medical Center   (United States)

^e Phoenix Memorial Hospital   (United States)

^f NewYork Presbyterian Hospital   (United States)

Author keywords

bypass graft; coronary artery disease; stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE MB; POLITEF; THIENOPYRIDINE DERIVATIVE;

ADULT; AGED; ANGIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POLITEF IMPLANT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; Q WAVE; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SAPHENOUS VEIN GRAFT; STENT THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; POLYTETRAFLUOROETHYLENE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79953016176     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.11.013     Document Type: Article

References (27)

1. J.H. Alexander, G. Hafley, R.A. Harrington PREVENT IV Investigators Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial JAMA 294 2005 2446 2454 (Pubitemid 41627922)
2. G.M. Fitzgibbon, H.P. Kafka, A.J. Leach, W.J. Keon, G.D. Hooper, and J.R. Burton Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J Am Coll Cardiol 28 1996 616 626 (Pubitemid 26288642)
3. P.J. Shah, I. Gordon, and J. Fuller Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999 J Thorac Cardiovasc Surg 126 2003 1972 1977 (Pubitemid 38020761)
4. M.K. Hong, R. Mehran, and G. Dangas Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results J Am Coll Cardiol 38 2001 150 154 (Pubitemid 32613842)
5. E.C. Keeley, C.A. Velez, W.W. O'Neill, and R.D. Safian Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts J Am Coll Cardiol 38 2001 659 665 (Pubitemid 32835732)
6. D.S. Baim, D. Wahr, and B. George Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts Circulation 105 2002 1285 1290 (Pubitemid 34260417)
7. G.W. Stone, C. Rogers, and J. Hermiller Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts Circulation 108 2003 548 553 (Pubitemid 36961168)
8. M.P. Savage, J.S. Douglas Jr., D.L. Fischman Saphenous Vein De Novo Trial Investigators Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts N Engl J Med 337 1997 740 747 (Pubitemid 27417973)
9. P. Vermeersch, P. Agostoni, and S. Verheye Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial J Am Coll Cardiol 50 2007 261 267 (Pubitemid 47039289)
10. E.S. Brilakis, C. Lichtenwalter, and J.A. de Lemos A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (stenting of saphenous vein Grafts) trial J Am Coll Cardiol 53 2009 919 928
11. U. Gercken, A.J. Lansky, and L. Buellesfeld Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results Catheter Cardiovasc Interv 56 2002 353 360 (Pubitemid 34693892)
12. A.J. Lansky, Y.M. Yang, and Y. Khan Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft Am J Cardiol 98 2006 370 374 (Pubitemid 44062447)
13. C. Briguori, J. De Gregorio, and T. Nishida Polytetrafluoroethylene- covered stent for the treatment of narrowings in aorticocoronary saphenous vein grafts Am J Cardiol 86 2000 343 346 (Pubitemid 30462237)
14. S. Baldus, R. Kster, and M. Elsner Treatment of aortocoronary vein graft lesions with membrane-covered stents: a multicenter surveillance trial Circulation 102 2000 2024 2027
15. G. Stankovic, A. Colombo, and P. Presbitero Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial Circulation 108 2003 37 42 (Pubitemid 36859017)
16. V. Schchinger, C.W. Hamm, and T. Mnzel A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts J Am Coll Cardiol 42 2003 1360 1369 (Pubitemid 37267273)
17. P.P. de Jaegere, R.T. van Domburg, and P.J. Feyter Long-term clinical outcome after stent implantation in saphenous vein grafts J Am Coll Cardiol 28 1996 89 96 (Pubitemid 26266627)
18. A.J. Lansky, G. Dangas, and R. Mehran Quantitative angiographic methods for appropriate endpoint analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation J Am Coll Cardiol 39 2002 274 280 (Pubitemid 34084633)
19. M. Elsner, W. Auch-Schwelk, M. Britten, D.H. Walter, V. Schchinger, and A.M. Zeiher Coronary stent grafts covered by a polytetrafluoroethylene membrane Am J Cardiol 84 1999 335 338 (Pubitemid 29365135)
20. S. Tsai, J. Butler, S. Rafii, B. Liu, and K.C. Kent The role of progenitor cells in the development of intimal hyperplasia J Vasc Surg 49 2009 502 510
21. O. van Oostrom, J.O. Fledderus, D. de Kleijn, G. Pasterkamp, and M.C. Verhaar Smooth muscle progenitor cells: friend or foe in vascular disease? Curr Stem Cell Res Ther 4 2009 131 140
22. E. Semiz, C. Ermi, S. Yalinkaya, O. Sancaktar, and N. Deer Comparison of initial efficacy and long-term follow-up of heparin-coated Jostent with conventional NIR stent Jpn Heart J 44 2003 889 898 (Pubitemid 41518945)
23. M.A. Turco, M. Buchbinder, and J.J. Popma Pivotal, randomized U.S. study of the Symbiot covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial Catheter Cardiovasc Interv 68 2006 379 388 (Pubitemid 44330675)
24. L. Ge, I. Iakovou, and G.M. Sangiorgi Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome J Am Coll Cardiol 45 2005 989 994 (Pubitemid 40432427)
25. A. Assali, Y. Raz, and H. Vaknin-Assa Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions EuroIntervention 4 2008 108 114
26. J.H. Alexander, G. Hafley, R.A. Harrington PREVENT IV Investigators Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery JAMA 294 2005 2446 2454 (Pubitemid 41627922)
27. D.S. Baim Percutaneous treatment of saphenous vein graft disease: the ongoing challenge J Am Coll Cardiol 42 2003 1370 1372 (Pubitemid 37267274)